Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ESSA Pharma Inc EPIX

Healthcare Biotechnology
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a... see more

Bullboard (NDAQ:EPIX)

View:
1 2 3 4 5 Next
User Avatar Image
(63)
•••
  • IseneschalX
Post by Iseneschalon Oct 26, 2022 2:25pm

EPIX ..... I have to laugh at myself ; )

Funny how my emotions come back to haunt me ...... I made a $1 per share profit but I left about $2 on the table.....ya just never know how high the share price will go This really surpassed my ...more  
96
User Avatar Image
(63)
•••
  • IseneschalX
Post by Iseneschalon Oct 26, 2022 10:33am

EPIX ..... Yeeeehaaaaa !

Now Over $3...... Cha f'king Ching !!!!
45
User Avatar Image
(63)
•••
  • IseneschalX
Post by Iseneschalon Oct 26, 2022 9:25am

EPIX ....On watch list

Relative volume and NR.....$2.07
59
User Avatar Image
(14)
•••
  • allison5120X
Post by allison5120on Oct 24, 2021 6:10pm

ESSA has begun recruiting for its phase 1/2 combo trial

ESSA has filed an update on clinicaltrials.gov announcing that it has begun recruiting patients for its phase 1/2 combination trial (EPI-7386 and Astellas/Pfizer's Enzalutimide). This is ...more  
125
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Nov 25, 2020 9:15am

Evercore SII 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore SII 3rd Annual HealthCONx Conference       HOUSTON and VANCOUVER, BC, Nov. 25, 2020 /CNW/ - ESSA Pharma ...more  
735
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Nov 11, 2020 6:33am

Upcoming Investor Conferences

ESSA Pharma to Participate in Upcoming Investor Conferences       HOUSTON and VANCOUVER, BC, Nov. 10, 2020 /CNW/ - ESSA Pharma Inc.  ...more  
110
User Avatar Image
(1)
•••
  • SilentRiverX
Comment by SilentRiveron Oct 27, 2020 7:31am

RE:Delisting from the TSX-V

Can someone tell me how that affects shares owned through the tsx? What happens to them? Thanks
106
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Oct 27, 2020 7:29am

Delisting from the TSX-V

ESSA Pharma Inc. Announces Delisting from the TSX-V       HOUSTON and VANCOUVER, BC, Oct. 26, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA" or the ...more  
148
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Oct 26, 2020 6:34am

Presents Therapeutic Potential of EPI-7386

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium HOUSTON and VANCOUVER, BC, Oct. 24, 2020 /CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX ...more  
99
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Oct 20, 2020 7:46am

Multiple Abstracts Accepted for Presentation

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia       HOUSTON, Texas and VANCOUVER, BC,  ...more  
61
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Sep 25, 2020 6:12am

Insider buying

How was he able to buy shares on the public market at $6.40? I'd like some shares at $6.40. Filed 2020-09-24 17:25   Tx date 2020-09-24 ...more  
97
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Sep 21, 2020 8:59am

ESSA Pharma / Oppenheimer Fall Healthcare Li

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit       HOUSTON and VANCOUVER, BC, Sept. 21, 2020 /CNW/ -& ...more  
76
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Sep 18, 2020 5:33am

Presentation of Additional Preclinical Data for EPI-7386

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020       HOUSTON and VANCOUVER, BC,  ...more  
94
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Sep 15, 2020 5:32am

Fast Track Designation Granted by the FDA

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer       HOUSTON and& ...more  
96
User Avatar Image
(1)
•••
  • SilentRiverX
Post by SilentRiveron Sep 14, 2020 6:53am

Upcoming Investor Conferences

ESSA Pharma to Participate in Multiple Upcoming Investor Conferences       HOUSTON and VANCOUVER, BC, Sept. 10, 2020 /CNW/ -  ...more  
114
1 2 3 4 5 Next